Seeking Alpha

Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
Healio

Q&A: Broader reach of blood-based biomarkers for Alzheimer’s can shift dynamics of access

Please provide your email address to receive an email when new articles are posted on . Labcorp said its national network can ease burdens of access to testing for Alzheimer’s disease. Blood-based ...
sciencex

Duke, LabCorp combine forces to create the Biomarker Factory

Duke University Medical Center and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the formation of a joint venture to commercialize new biomarkers. The new entity is ...
Nasdaq

Labcorp Launches Blood-Based Biomarker Test For Alzheimer's Diagnosis

(RTTNews) - Labcorp (LH) Wednesday has introduced the pTau-217/Beta Amyloid 42 Ratio test, a blood-based biomarker designed to aid in Alzheimer's diagnosis. Offering accuracy comparable to PET imaging ...
Seeking Alpha

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 ...
GEN

Better Biomarkers for Better Medicines

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...